medpagetoday.com
Gynecological growths should enter the cardiology conversation, population-based study suggests
14 days ago
medpagetoday.com
Recent developments of interest in cardiovascular medicine
16 days ago
medpagetoday.com
Eliminating high-caffeine beverages may reverse some harms, case report suggests
16 days ago
medpagetoday.com
ACC makes its case for front-of-package nutrition labeling
20 days ago
medpagetoday.com
Ventura transcatheter device found no support on efficacy at a critical FDA advisory committee
21 days ago
medpagetoday.com
Recent developments of interest in cardiovascular medicine
23 days ago
medpagetoday.com
Standard cardiovascular risk assessment dinged for individual-level prediction
about 1 month ago
medpagetoday.com
The small interfering RNA therapy is approved for familial chylomicronemia syndrome
about 1 month ago
medpagetoday.com
Recent developments of interest in cardiovascular medicine
about 1 month ago
medpagetoday.com
'We don't want to wait until it is too late,' researcher says
about 1 month ago
medpagetoday.com
BMJ issues 'expression of concern' about much-publicized phase III study
about 1 month ago
medpagetoday.com
Phase III trials of nex-z stay on clinical hold after a liver-related death
about 1 month ago
medpagetoday.com
Large observational study compared users versus non-users with insomnia
about 1 month ago
medpagetoday.com
Recent developments of interest in cardiovascular medicine
about 1 month ago
medpagetoday.com
Developments also anticipated in Afib treatment
about 2 months ago
medpagetoday.com
Bidirectional associations observed in population-based cohort study
about 2 months ago
medpagetoday.com
Great expectations for sensitivity, specificity of iodine-124 evuzamitide PET imaging
about 2 months ago
medpagetoday.com
Deferred stress cardiac MRI-guided PCI ofnon-culprit lesions sufficed in iMODERN
about 2 months ago
medpagetoday.com
Tendyne device also shows promise for desperate MR patients
about 2 months ago
medpagetoday.com
Recent developments of interest in cardiovascular medicine
about 2 months ago
medpagetoday.com
PARTNER 3 trial continues to probe TAVR's durability
about 2 months ago